EN
HI
Solara Active Pharma Sciences - (Partly Paid-up Equity Shares (Rights Issue)) Chart
Solara Active Pharma Sciences - (Partly Paid-up Equity Shares (Rights Issue)) Share Key Metrics
Volume
71.00
Market Cap
340.49 CR
LTQ@LTP
3@289.45
ATP
292.94
Var Margin
25.87 %
Circuit Range
232-348
Delivery %
89.81 %
Value
20798.74
ASM/GSM
No
Market Lot
1
Summary
At 13 Mar, 2026 | 09:46, Solara Active Pharma Sciences - (Partly Paid-up Equity Shares (Rights Issue)) share price stands at ₹289.45, showing a 0.55% -0.19 for the day. The stock’s intraday movement has stayed between ₹288.05 and ₹340.00, while on a 52-week basis it has fluctuated from ₹288.05 to ₹524.90.
In terms of trading activity, Solara Active Pharma Sciences - (Partly Paid-up Equity Shares (Rights Issue)) has recorded a volume of 71 shares, with a market capitalisation of ₹11741163. The stock’s Average Traded Price (ATP) stands at ₹29294, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 3,28945. The stock operates within a circuit range of ₹232-348, with a Value of ₹20798.74. The Delivery Percentage for the day is 89.81%. Additionally, Solara Active Pharma Sciences - (Partly Paid-up Equity Shares (Rights Issue)) currently falls under the No framework, and trades with a market lot size of 1.
Solara Active Pharma Sciences - (Partly Paid-up Equity Shares (Rights Issue)) Fundamentals
View MoreP/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
60.72
Sector P/B
2.7
Sec. Div. Yield
0.58
Solara Active Pharma Sciences - (Partly Paid-up Equity Shares (Rights Issue)) Resistance and Support
Pivot 290.97
Resistance
First Resistance
291.94
Second Resistance
293.87
Third Resistance
294.84
Support
First Support
289.04
Second Support
288.07
Third Support
286.14
Solara Active Pharma Sciences - (Partly Paid-up Equity Shares (Rights Issue)) Corporate Actions
| Date | Agenda | |||
|---|---|---|---|---|
 | ||||
Solara Active Pharma Sciences - (Partly Paid-up Equity Shares (Rights Issue)) News
About Solara Active Pharma Sciences - (Partly Paid-up Equity Shares (Rights Issue))
NSE : 756939
BSE : 890202
ISIN : IN9624Z01022
Solara Active Pharma Sciences - (Partly Paid-up Equity Shares (Rights Issue)) Management
| Name | Position |
|---|
Solara Active Pharma Sciences - (Partly Paid-up Equity Shares (Rights Issue)) Similar Stocks
Solara Active Pharma Sciences - (Partly Paid-up Equity Shares (Rights Issue)) FAQs
The Buying Price of Solara Active Pharma Sciences - (Partly Paid-up Equity Shares (Rights Issue)) share is 289.45 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Solara Active Pharma Sciences - (Partly Paid-up Equity Shares (Rights Issue)) stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Solara Active Pharma Sciences - (Partly Paid-up Equity Shares (Rights Issue)), choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Solara Active Pharma Sciences - (Partly Paid-up Equity Shares (Rights Issue)) shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Solara Active Pharma Sciences - (Partly Paid-up Equity Shares (Rights Issue)) shares is 0. Useful to assess the stock's value relative to its book value.
To assess Solara Active Pharma Sciences - (Partly Paid-up Equity Shares (Rights Issue))’s valuation compare Sector P/E, P/B which are 60.72 & 2.7 with sector averages, along with growth rates and financial metrics.
The Market Cap of Solara Active Pharma Sciences - (Partly Paid-up Equity Shares (Rights Issue)) is 340.49 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Solara Active Pharma Sciences - (Partly Paid-up Equity Shares (Rights Issue)) share price is 524.90 & 288.05. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Solara Active Pharma Sciences - (Partly Paid-up Equity Shares (Rights Issue)) belongs to the Healthcare sector.
